ALNT: Allient Inc. Stock

by  •  • Comments Off on ALNT: Allient Inc. Stock

SIC 3825 – Instruments for Measuring and Testing of Electricity and Electrical Signals

Valuation
Market Cap ($M) 533.77
Enterprise Value ($M) 700.18
Book Value ($M) 272.83
Book Value / Share 16.12
Price / Book 1.96
NCAV ($M) -60.20
NCAV / Share -3.56
Price / NCAV -8.87

Profitability (mra)
Return on Invested Capital (ROIC) 0.02
Return on Assets (ROA) 0.02
Return on Equity (ROE) 0.04

Liquidity (mrq)
Quick Ratio 2.35
Current Ratio 4.03

Balance Sheet (mrq) ($M)
Current Assets 253.87
Assets 586.90
Liabilities 314.07
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 529.97
Operating Income 32.45
Net Income 13.17
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 41.85
Cash from Investing -34.91
Cash from Financing -0.84

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
04-17 13G/A BlackRock, Inc. 5.90 -30.00
02-07 13G/A Fmr Llc 9.50 38.15
11-12 13G/A Vanguard Group Inc 5.11 0.00
11-06 13D Juniper Investment Company, LLC 5.20

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-05-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q
2025-03-05 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K
2024-11-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q
2024-08-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-14 20,939 91,477 22.89
2025-05-13 27,035 130,777 20.67
2025-05-12 20,383 122,417 16.65
2025-05-09 39,829 223,886 17.79

(click for more detail)

Similar Companies
CAMT – Camtek Ltd. EYPT – EyePoint Pharmaceuticals, Inc.


Financial data and stock pages provided by
Fintel.io